Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00137982
Recruitment Status : Unknown
Verified August 2005 by Hopital Antoine Beclere.
Recruitment status was:  Recruiting
First Posted : August 30, 2005
Last Update Posted : September 8, 2006
Information provided by:
Hopital Antoine Beclere

August 29, 2005
August 30, 2005
September 8, 2006
August 2004
Not Provided
Subsequent fertility with 2 years follow-up
Same as current
Complete list of historical versions of study NCT00137982 on Archive Site
  • Complications of treatments
  • Time of hospitalisation
  • Decrease curve of beta-hCG after treatment
  • Success rate in each group
Same as current
Not Provided
Not Provided
Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility
Prospective Study, Randomized Controlled Trial Between Medical Treatment by Methotrexate Versus Conservative Surgical Treatment (Group 1) and Conservative Versus Radical Surgical Treatment (Group 2) to Evaluate Subsequent Fertility
Three protocols are used to treat ectopic pregnancies: medical treatment by methotrexate, conservative surgery or radical surgery. There are no data about subsequent fertility except in a cohort study. The investigators propose to evaluate the true subsequent fertility with a follow-up of 2 years, in a randomized controlled trial.
The first group includes non active ectopic pregnancies defined by score or algorithm. In this case, we propose a randomized controlled trial between medical and conservative surgery. In all others clinical situations, we proposed surgery treatment. In a randomized controlled trial we compare conservative versus radical treatment. The patients are followed-up during 2 years with phone contact every 6 months.
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Tubal Pregnancy
Procedure: Treatment of ectopic pregnancy
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Unknown status
Same as current
July 2008
Not Provided

Inclusion Criteria:

  • Diagnosis by ultra sound of ectopic pregnancy (EP)
  • Patients aged > 18 years old
  • Desire of future pregnancy

Exclusion Criteria:

  • EP by failure of contraception
  • EP associated with in vitro fertilization (IVF)
Sexes Eligible for Study: Female
18 Years to 44 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Not Provided
Hopital Antoine Beclere
Not Provided
Study Chair: Fernandez Hervé, PhD MD Hopital Antoine Beclere
Hopital Antoine Beclere
August 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP